TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3172191

Group type: EXPERIMENTAL
Intervention: High-caloric snack (chocolate milkshake)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Preload (milkshake)
Number of subjects: 102

Group type: COMPARATOR
Intervention: No preload (no milkshake)
Number of subjects: 102
Study: 31876704

Group type: EXPERIMENTAL
Intervention: Mometasone furoate cream (MMF) applied once a day from the date of first radiotherapy until 2 weeks after end of radiotherapy or until ARD lesions developed.
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Mometasone furoate cream (MMF) applied once a day.
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control side (no medication applied).
Number of subjects: 41
Study: 26882533

Group type: EXPERIMENTAL
Intervention: Pilates exercise program (3 times per week for 4 weeks)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Connective tissue massage (CTM) (3 times per week for 4 weeks)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pilates exercise program
Number of subjects: 21
Study: 25119563

Group type: EXPERIMENTAL
Intervention: Prolene Hernia System (PHS)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Mesh Plug Repair (MPR)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Lichtenstein (L) technique
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Follow-up at 8 years
Number of subjects: 270
Study: 22740100

Group type: EXPERIMENTAL
Intervention: Worksite lifestyle intervention (6-month duration, including two weekly guided group sessions: one yoga and one workout, one weekly session of aerobic exercising, and three individual coach visits)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Yoga subgroup analysis (high yoga compliers)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Workout subgroup analysis (high workout compliers)
Number of subjects: 367
Study: 22020346

Group type: EXPERIMENTAL
Intervention: Ketamine (0.8 mg/kg per hour during 80 minutes with approximate target plasma levels of 200 ng/mL)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 18274270

Group type: EXPERIMENTAL
Intervention: Periodic leg movement index, time in bed, age
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Periodic leg movement index
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Time in bed
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Apnea-hypopnea index
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Oxygen saturation nadir
Number of subjects: 102
Study: 19759970

Group type: EXPERIMENTAL
Intervention: Instructional CD
Number of subjects: 50

Group type: COMPARATOR
Intervention: Live demonstration
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Instructional CD and Live demonstration
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Program 2
Number of subjects: 50
Study: 14632207

Group type: EXPERIMENTAL
Intervention: Sunscreen with high ultraviolet A absorption (ultraviolet A protection factor of 10, SPF 15)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Sunscreen with low ultraviolet A absorption (ultraviolet A protection factor of 2, SPF 15)
Number of subjects: 211
Study: 10712996

Group type: EXPERIMENTAL
Intervention: Generic albuterol metered-dose inhaler (MDI) - 1 actuation (90 microg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Generic albuterol metered-dose inhaler (MDI) - 4 actuations (360 microg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ventolin metered-dose inhaler (MDI)
Number of subjects: 24
Study: 9052321

Group type: EXPERIMENTAL
Intervention: Pancuronium 10 micrograms/kg followed by pancuronium 2.5 micrograms.kg‐1.h‐1
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (pancuronium and control)
Number of subjects: 30
Study: 1390328

Group type: EXPERIMENTAL
Intervention: Verapamil (5 mg intravenously and 80 mg tid orally)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 3903528

Group type: EXPERIMENTAL
Intervention: 160 mg/day i.v. for 3 days, then oral MP (0.8 mg/kg/day) tapered by 4 mg/week to 16 mg/day
Number of subjects: 100

Group type: COMPARATOR
Intervention: 80 mg/day i.v. for 3 days, then oral MP (0.4 mg/kg/day) tapered by 2 mg/week to 16 mg/day
Number of subjects: 100
Study: 31820600

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with tropisetron hydrochloride (5 mg, slow intravenous injection, once a day for 3 days) in No.1 observation group.
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Acupuncture after chemotherapy combined with tropisetron hydrochloride (5 mg, slow intravenous injection, once a day for 3 days) in No.2 observation group.
Number of subjects: 150

Group type: COMPARATOR
Intervention: Tropisetron hydrochloride (5 mg, slow intravenous injection, once a day for 3 days) in control group.
Number of subjects: 150
Study: 30322824

Group type: EXPERIMENTAL
Intervention: Minocycline (200 mg per day for 2 weeks, then 300 mg per day for the remainder of the 12‐month study period)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 207
Study: 27086089

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg once daily for 3 to 7 days preoperatively until 14 days postoperatively
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 132
Study: 24835634

Group type: EXPERIMENTAL
Intervention: BCI trained subjects
Number of subjects: 18

Group type: COMPARATOR
Intervention: Naive subjects
Number of subjects: 18
Study: 22425649

Group type: EXPERIMENTAL
Intervention: Exposure to a screensaver showing skinny human-like sculptures (Alberto Giacometti)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indicating body weight before tasting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Indicating body weight after tasting
Number of subjects: 0
Study: 21151070

Group type: EXPERIMENTAL
Intervention: VLE tutorial
Number of subjects: 30

Group type: COMPARATOR
Intervention: Face-to-face seminar
Number of subjects: 30
Study: 17604332

Group type: EXPERIMENTAL
Intervention: Ketorolac Bier block (6 mg of ketorolac tromethamine in saline)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline Bier block (control)
Number of subjects: 12
Study: 15638860

Group type: EXPERIMENTAL
Intervention: Patient self-testing (PST) using CoaguChek S
Number of subjects: 84

Group type: COMPARATOR
Intervention: Hospital laboratory monitoring of INR (control)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Patient self-testing (PST)
Number of subjects: 84
Study: 12373063

Group type: EXPERIMENTAL
Intervention: Tracheal aspiration (TA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bronchoalveolar lavage (BAL)
Number of subjects: 40
Study: 9925043

Group type: EXPERIMENTAL
Intervention: Cessation intervention (unsolicited smoking cessation intervention)
Number of subjects: 1219
Study: 7498224

Group type: EXPERIMENTAL
Intervention: 99mTc-ECD
Number of subjects: 22

Group type: COMPARATOR
Intervention: 99mTc-HMPAO
Number of subjects: 22
Study: 2106402

Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (DDAVP) 0.3 microgram/kg body weight infused over 15 minutes
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 19
Study: 7208541

Group type: EXPERIMENTAL
Intervention: 500 mg pivampicillin twice daily
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: 350 mg pivampicillin 3-times a day
Number of subjects: 211
Study: 31677411

Group type: EXPERIMENTAL
Intervention: 24 IU oxytocin
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 31294600

Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU)
Number of subjects: 321
Study: 28784120

Group type: EXPERIMENTAL
Intervention: Kiosk-based educational intervention on blood pressure control
Number of subjects: 38

Group type: COMPARATOR
Intervention: Commonly prescribed antihypertensive medication
Number of subjects: 38
Study: 25777090

Group type: EXPERIMENTAL
Intervention: Dietary intake (DI) group
Number of subjects: 59
Study: 23820108

Group type: EXPERIMENTAL
Intervention: ARCON (accelerated radiotherapy with carbogen and nicotinamide)
Number of subjects: 342

Group type: COMPARATOR
Intervention: CON (radiotherapy alone)
Number of subjects: 342
Study: 21098832

Group type: EXPERIMENTAL
Intervention: Workplace intervention aimed at reducing adverse psychosocial work factors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 19450037

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy plus hypnosis (CBTH) in addition to standard medical care (SMC) (n = 22)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard medical care (SMC) (n = 20)
Number of subjects: 42
Study: 17699799

Group type: EXPERIMENTAL
Intervention: Lowest quartile of plasma IGFBP‐1
Number of subjects: 573

Group type: COMPARATOR
Intervention: Three highest quartiles of plasma IGFBP‐1
Number of subjects: 573
Study: 15000763

Group type: EXPERIMENTAL
Intervention: Oralin spray (100 U)
Number of subjects: 21

Group type: COMPARATOR
Intervention: OHAs (metformin + glyburide)
Number of subjects: 21
Study: 11577956

Group type: EXPERIMENTAL
Intervention: Liver cirrhosis group (LC)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Post-transplantation group (PT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: CsA-treated patients
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Tacrolimus-treated patients
Number of subjects: 54
Study: 9520217

Group type: EXPERIMENTAL
Intervention: Motor imagery training for 10 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control visuomotor task for 10 minutes
Number of subjects: 0
Study: 7851712

Group type: EXPERIMENTAL
Intervention: Rapid test
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard enzymatic method
Number of subjects: 500

Group type: COMPARATOR
Intervention: Comparison of tests
Number of subjects: 500
Study: 2548862

Group type: EXPERIMENTAL
Intervention: NaHCO3 (alkalotic)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: NH4Cl (acidotic)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 6
Study: 1247038

Group type: EXPERIMENTAL
Intervention: Electric pulse as the unconditioned stimulus for classical eyelid conditioning
Number of subjects: 2
Study: 28445231

Group type: EXPERIMENTAL
Intervention: Multi-Day Dosing Group (n = 14)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Single Pre-Exercise Dosing Group (n = 15)
Number of subjects: 29
Study: 26548543

Group type: EXPERIMENTAL
Intervention: Caring for the Caregivers intervention (multimodal approach to stress-reduction with five components: cognitive, somatic, dynamic, emotive, and hands-on) over eight months
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Caring for the Caregivers intervention
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (67 individuals)
Number of subjects: 97
Study: 26010235

Group type: EXPERIMENTAL
Intervention: e‐SBI plus tailored mailings
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control session on infant nutrition
Number of subjects: 48
Study: 23905684

Group type: EXPERIMENTAL
Intervention: MMPI-2-RF validity scales
Number of subjects: 140
Study: 22384612

Group type: EXPERIMENTAL
Intervention: Stimulation with internal coasting (225 IU hMG for 2 days, 2 days without hMG, then 150 IU hMG for the remainder)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Standard doses of hMG (control group)
Number of subjects: 139
Study: 19885943

Group type: EXPERIMENTAL
Intervention: Acupoint stimulation intervention for quitting smoking
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham acupoint intervention
Number of subjects: 59
Study: 17416005

Group type: EXPERIMENTAL
Intervention: Carbon ion radiotherapy (C-ion RT)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Intensity-modulated radiotherapy (IMRT)
Number of subjects: 5
Study: 12734766

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 12
Study: 11122888

Group type: EXPERIMENTAL
Intervention: Increased dose intensity during induction therapy
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Related-donor allogeneic bone marrow transplantation
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Purged autologous bone marrow transplantation and standard chemotherapy consolidation
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Autologous transplantation and chemotherapy
Number of subjects: 1200
Study: 9052515

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 10
Study: 8333807

Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 300

Group type: COMPARATOR
Intervention: Recumbent position
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Sitting position (symptomatic patients)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: History of fainting (symptomatic patients)
Number of subjects: 300
Study: 3571768

Group type: EXPERIMENTAL
Intervention: Bitolterol mesylate, 1.0 mg, administered three times daily for 3 months
Number of subjects: 182

Group type: COMPARATOR
Intervention: Isoproterenol hydrochloride, 1.5 mg, administered three times daily for 3 months
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Bitolterol mesylate
Number of subjects: 182

Group type: COMPARATOR
Intervention: Isoproterenol hydrochloride
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 182
Study: 29540327

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 27054529

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 24595613

Group type: EXPERIMENTAL
Intervention: Mini-subvastus approach (group I)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard approach (group II)
Number of subjects: 68
Study: 23059436

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 92
Study: 20332388

Group type: EXPERIMENTAL
Intervention: Intervention (classroom sessions promoting sun protection and provision of two free wide-brimmed hats)
Number of subjects: 2491

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 2491

Group type: EXPERIMENTAL
Intervention: Intervention (self-reported hat use outside of school)
Number of subjects: 2491

Group type: COMPARATOR
Intervention: Control (self-reported hat use outside of school)
Number of subjects: 2491

Group type: EXPERIMENTAL
Intervention: Intervention (skin pigmentation measurements)
Number of subjects: 2491

Group type: COMPARATOR
Intervention: Control (skin pigmentation measurements)
Number of subjects: 2491
Study: 18302679

Group type: EXPERIMENTAL
Intervention: 2% minocycline hydrochloride ointment applied once into the pocket
Number of subjects: 91

Group type: COMPARATOR
Intervention: Sterilized physiological saline irrigation
Number of subjects: 91
Study: 15672057

Group type: EXPERIMENTAL
Intervention: Endoscopic variceal ligation
Number of subjects: 73

Group type: COMPARATOR
Intervention: Endoscopic sclerotherapy
Number of subjects: 73
Study: 12846762

Group type: EXPERIMENTAL
Intervention: Kt/V target group A (1.5 to 1.7)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Kt/V target group B (1.7 to 2.0)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Kt/V target group C (>2.0)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Total Kt/V
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Serum albumin and CNI scores
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) treatment
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Overall 2-year patient survival
Number of subjects: 320
Study: 10761820

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other antipsychotic drugs
Number of subjects: 0
Study: 8872633

Group type: EXPERIMENTAL
Intervention: Thiorphan (inhaled, 0.5 ml containing 1.25 mg/ml, administered by two inhalations)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 1997056

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 1.0% ropivacaine
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 0.75% bupivacaine
Number of subjects: 110

Group type: COMPARATOR
Intervention: Comparison of ropivacaine and bupivacaine at the same concentration
Number of subjects: 110

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 110
Study: 6858932

Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30012527

Group type: EXPERIMENTAL
Intervention: IMRT-DIBH
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard radiotherapy
Number of subjects: 62
Study: 26948543

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE) - 4 × 4 min at 90%-95% of maximal heart rate, three times a week, 120 min/week, n=24
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Exercise (MIE) - 210 min/week, n=23
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no intervention), N=37
Number of subjects: 47
Study: 24268702

Group type: EXPERIMENTAL
Intervention: Laparoscopic electrocautery of the ovaries
Number of subjects: 168

Group type: COMPARATOR
Intervention: Gonadotropins
Number of subjects: 168
Study: 22640924

Group type: EXPERIMENTAL
Intervention: Patient-preference, stepped care protocol for depression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Referred care arm decided by primary care provider
Number of subjects: 0
Study: 20452781

Group type: EXPERIMENTAL
Intervention: Green tea ingestion (3 breakfast cups, 540 ml total)
Number of subjects: 10
Study: 19090602

Group type: EXPERIMENTAL
Intervention: Viscous fiber blend biscuits (10 g of highly viscous fiber blend)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control biscuits (50 g available carbohydrates)
Number of subjects: 19

Group type: COMPARATOR
Intervention: White bread with 12 g of margarine
Number of subjects: 19

Group type: COMPARATOR
Intervention: White bread alone
Number of subjects: 19
Study: 15951457

Group type: EXPERIMENTAL
Intervention: Patient‐specific, evidence‐based decision aid
Number of subjects: 386

Group type: COMPARATOR
Intervention: Usual care (informational pamphlet)
Number of subjects: 386
Study: 12947360

Group type: EXPERIMENTAL
Intervention: Metabolic syndrome
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering medication
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 425
Study: 10783843

Group type: EXPERIMENTAL
Intervention: Braun Oral‐B Ultra Plaque Remover (D9)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Philips/Jordan HP 735
Number of subjects: 23
Study: 9863160

Group type: EXPERIMENTAL
Intervention: E2‐WTCDS
Number of subjects: 18

Group type: COMPARATOR
Intervention: E2‐TTS (control)
Number of subjects: 18
Study: 2068950

Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxyvitamin D3 (2 micrograms)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Prednisone (10 mg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxyvitamin D3 (2 micrograms) + Prednisone (10 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 6631978

Group type: EXPERIMENTAL
Intervention: Combination of sexual awareness, relaxation and breathing (SARB group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pubococcygeal exercises (PC group)
Number of subjects: 0
Study: 31378962

Group type: EXPERIMENTAL
Intervention: moxifloxacin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: dofetilide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ondansetron
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: dolasetron
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: quinine
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: levocetirizine
Number of subjects: 20
Study: 30665339

Group type: EXPERIMENTAL
Intervention: Monitored Cooperative High-Intensity Interval Training (C-HIIT)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Static stretching (Control)
Number of subjects: 158
Study: 27686663

Group type: EXPERIMENTAL
Intervention: Mydrin eye-drops (tropicamide and phenylephrine hydrochloride)
Number of subjects: 60
Study: 27373438

Group type: EXPERIMENTAL
Intervention: CHF6001 400 μg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: CHF6001 1200 μg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 24725800

Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Trigger point compression technique (TCT)
Number of subjects: 33
Study: 22428941

Group type: EXPERIMENTAL
Intervention: Teacher consultation and coaching program (training + consultation/coaching)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Training only (Control)
Number of subjects: 364
Study: 19146755

Group type: EXPERIMENTAL
Intervention: Line-probe assay (LiPA) for rapid detection of rifampicin resistance
Number of subjects: 143

Group type: COMPARATOR
Intervention: Conventional drug susceptibility testing (DST)
Number of subjects: 143
Study: 17469130

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Heavy smoking (total of >20 pack-years)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Former smokers and those who had never smoked
Number of subjects: 325

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 325
Study: 11195234

Group type: EXPERIMENTAL
Intervention: Low-dose cisapride (0.1 mg/kg given 8 hourly)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9124832

Group type: EXPERIMENTAL
Intervention: Daily primaquine (0.5 mg of base per kg of body weight per day)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Weekly chloroquine (300 mg of base one time per week)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129